# A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)

> **NCT05567354** · PHASE1 · COMPLETED · sponsor: **Ensysce Biosciences** · enrollment: 27 (actual)

## Conditions studied

- Recreational Drug Use

## Interventions

- **DRUG:** PF614
- **DRUG:** Oxycodone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05567354
- **Lead sponsor:** Ensysce Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-10
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05567354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05567354, "A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05567354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*